Search results

Page results

• Covid-19 vaccine: Common stroke symptoms must be ‘urgently evaluated’

  UCLH and UCL neurologists have published the first clinical observations of patients who experienced an ischaemic stroke, the most common form of stroke, following an Oxford AstraZeneca vaccine.

• Drug combination could be new lupus treatment

  A combination of two drugs could be an effective treatment for the debilitating disease lupus, according to preliminary evidence from a UCLH led trial.

• Ward T16 North - Haematology

  T16 North is a specialist adult haematology inpatient ward dedicated to providing high-quality care for patients with a wide range of blood disorders.

• Guy Noble - arts curator

  Art and creativity can be a real tonic for health, says UCLH arts curator Guy Noble.

• Flow-diverting stents (in the treatment of intracranial aneurysms)

  The aim of this page is to provide you with information about flow-diverting stents and how they are used to treat cerebral (brain) aneurysms.

• Peer review shines spotlight on collaborative excellence and challenges at the Red Cell Network HCC

  Every five years, a national Peer Review process casts a supportive but critical eye over red cell services across the UK.

• Sarah, Duchess of York and Their Royal Highnesses Princesses Beatrice and Eugenie meet young people with cancer at UCLH

  In a joint public appearance, the trio, who are Honorary Patrons of Teenage Cancer Trust, visited the ward to meet young patients and thank staff for their work.

• Autolab - routine haemostasis/haematology

  A number of tests are carried out by the routine haemostasis/haematology laboratories. These include full blood count, ESR, sickle cell and glandular fever screening, malaria antigen testing, blood films and acanthocytes, coagulation screens (INR/heparin monitoring), fibrinogen and D-dimers (DIC screening).

• Inflammatory Bowel Disease and Pregnancy

  This page provides information for pregnant women with Inflammatory Bowel Disease.

• New clinical trial aims to improve diagnosis, treatment and rehabilitation of long COVID

  A major new consortium led by UCLH and UCL has been awarded £6.8 million by the National Institute of Health Research to conduct the largest clinical study of long COVID over the next two years.